Fulcrum Capital LLC Cuts Stake in CME Group Inc. $CME

Key Points

• Fulcrum Capital LLC reduced its stake in CME Group by 2.2% in the second quarter, now holding 42,428 shares valued at approximately $11.69 million.
• Multiple institutional investors have increased their holdings in CME Group, with Webster Bank N.A. growing its position by 206.9% in the second quarter.
• CME Group reported a 10.4% year-over-year increase in revenue, with earnings per share of $2.96, exceeding analyst estimates.

Fulcrum Capital LLC lowered its holdings in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 2.2% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 42,428 shares of the financial services provider's stock after selling 964 shares during the quarter. CME Group makes up 2.5% of Fulcrum Capital LLC's portfolio, making the stock its 13th biggest holding. Fulcrum Capital LLC's holdings in CME Group were worth $11,694,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in CME. Wayfinding Financial LLC purchased a new stake in shares of CME Group during the first quarter worth about $25,000. Webster Bank N. A. grew its position in shares of CME Group by 206.9% during the second quarter. Webster Bank N. A. now owns 89 shares of the financial services provider's stock worth $25,000 after purchasing an additional 60 shares in the last quarter. Cornerstone Planning Group LLC grew its position in shares of CME Group by 122.2% during the first quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider's stock worth $26,000 after purchasing an additional 55 shares in the last quarter. Highline Wealth Partners LLC grew its position in shares of CME Group by 84.3% during the second quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider's stock worth $26,000 after purchasing an additional 43 shares in the last quarter. Finally, Golden State Wealth Management LLC grew its position in shares of CME Group by 612.5% during the first quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider's stock worth $30,000 after purchasing an additional 98 shares in the last quarter. Hedge funds and other institutional investors own 87.75% of the company's stock.

Insider Activity

In other CME Group news, Director William R. Shepard purchased 262 shares of the firm's stock in a transaction that occurred on Thursday, September 25th. The stock was purchased at an average cost of $265.19 per share, with a total value of $69,479.78. Following the purchase, the director owned 258,459 shares of the company's stock, valued at approximately $68,540,742.21. The trade was a 0.10% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, General Counsel Jonathan L. Marcus sold 392 shares of the firm's stock in a transaction that occurred on Thursday, September 18th. The stock was sold at an average price of $262.00, for a total value of $102,704.00. Following the sale, the general counsel directly owned 7,851 shares of the company's stock, valued at $2,056,962. This represents a 4.76% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 13,043 shares of company stock valued at $3,527,956. Company insiders own 0.30% of the company's stock.

CME Group Price Performance

NASDAQ:CME opened at $271.45 on Friday. The firm has a market capitalization of $97.83 billion, a price-to-earnings ratio of 26.28, a PEG ratio of 5.67 and a beta of 0.41. CME Group Inc. has a 1 year low of $213.94 and a 1 year high of $290.79. The business has a 50 day simple moving average of $268.89 and a 200-day simple moving average of $271.17. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02.

CME Group (NASDAQ:CME - Get Free Report) last posted its quarterly earnings data on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.91 by $0.05. The business had revenue of $1.69 billion during the quarter, compared to analyst estimates of $1.68 billion. CME Group had a return on equity of 14.60% and a net margin of 58.48%.The company's revenue for the quarter was up 10.4% on a year-over-year basis. During the same period last year, the company earned $2.56 EPS. Equities analysts forecast that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, September 25th. Investors of record on Tuesday, September 9th were given a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a yield of 1.8%. The ex-dividend date of this dividend was Tuesday, September 9th. CME Group's dividend payout ratio is 48.40%.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on CME shares. Piper Sandler increased their price target on CME Group from $283.00 to $296.00 and gave the company an "overweight" rating in a research note on Tuesday, July 15th. Oppenheimer increased their price target on CME Group from $300.00 to $303.00 and gave the company an "outperform" rating in a research note on Thursday, July 24th. Jefferies Financial Group dropped their price target on CME Group from $313.00 to $304.00 and set a "buy" rating for the company in a research note on Friday. Morgan Stanley increased their price target on CME Group from $303.00 to $312.00 and gave the company an "overweight" rating in a research note on Wednesday, October 1st. Finally, Wall Street Zen lowered CME Group from a "hold" rating to a "sell" rating in a research note on Sunday, July 13th. Seven analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average price target of $281.00.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.